TheProfitWatch

LGVN - Longeveron Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.61 0.01 (0.83%) 0.0 (0.02%) 0.0 (0.02%) -0.01 (-2.38%) 0.0 (0.78%) 0.01 (1.68%) 0.0 (0.12%) 0.01 (1.06%)

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.34
Diluted EPS:
-0.34
Basic P/E:
-1.7944
Diluted P/E:
-1.7944
RSI(14) 1m:
51.3
VWAP:
0.61
RVol:

Events

Period Kind Movement Occurred At

Related News